Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Sep 7;41(34):3281-3282.
doi: 10.1093/eurheartj/ehaa520.

STAR evidence evaluation of viral fulminant myocarditis: Specificity, Timeliness, Accessibility, Risk

Si Wang  1 , Xin Wei  1 , Hongde Hu  1
Affiliations
Comment

STAR evidence evaluation of viral fulminant myocarditis: Specificity, Timeliness, Accessibility, Risk

Si Wang et al. Eur Heart J. .
No abstract available

PubMed Disclaimer

Figures

Take home figure
Take home figure
STAR evidence evaluation of viral fulminant myocarditis: Specificity, Timeliness, Accessibility, Risk. CMR, cardiac magnetic resonance; ECG, electrocardiogram; ECHO, echocardiography; EMB, endocardial myocardial biopsy; FM, Fulminant myocarditis; IHC, immunohistochemistry; LGE, late gadolinium enhancement; PCR, polymerase chain reaction. +, ++, +++, ++++, Score of the evaluated factor. ΔExclude coronary artery disease through selective coronary angiography, etc.
None
See this image and copyright information in PMC

Comment on

References

    1. Piperata A, Bottio T, Gerosa G. The importance of myocardial biopsy in the diagnosis of infectious myocarditis: it still plays a role. Eur Heart J 2020;41:3280. - PubMed
    1. Caforio ALP, Pankuweit S, Arbustini E, Basso C, Gimeno-Blanes J, Felix SB, Fu M, Helio T, Heymans S, Jahns R, Klingel K, Linhart A, Maisch B, McKenna W, Mogensen J, Pinto YM, Ristic A, Schultheiss H-P, Seggewiss H, Tavazzi L, Thiene G, Yilmaz A, Charron P, Elliott PM. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 2013;34:2636–2648. - PubMed
    1. Kociol RD, Cooper LT, Fang JC, Moslehi JJ, Pang PS, Sabe MA, Shah RV, Sims DB, Thiene G, Vardeny O; On behalf of the American Heart Association Heart Failure and Transplantation Committee of the Council on Clinical Cardiology. Recognition and initial management of fulminant myocarditis: a scientific statement from the American Heart Association. Circulation 2020;141:e69–e92. - PubMed
    1. Ammirati E, Cipriani M, Lilliu M, Sormani P, Varrenti M, Raineri C, Petrella D, Garascia A, Pedrotti P, Roghi A, Bonacina E, Moreo A, Bottiroli M, Gagliardone MP, Mondino M, Ghio S, Totaro R, Turazza FM, Russo CF, Oliva F, Camici PG, Frigerio M. Survival and left ventricular function changes in fulminant versus nonfulminant acute myocarditis. Circulation 2017;136:529–545. - PubMed
    1. Saito T, Katayama H, Kodani E. Is steroid therapy really banned for lymphocytic myocarditis before excluding viral infection? Eur Heart J 2019; 40:1014–1015. - PubMed

Publication types